Having recognized the palmitoylation motif of APLNR, we built a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web page together with morphine, can inhibit the development of NCP, such as pain incidence, microglial activation, and inflammatory aspect https://milovanu627iaq3.wikigop.com/user